Cargando…
Efficacy of therapeutic intervention with an oral ether–lipid analogue of cidofovir (CMX001) in a lethal mousepox model
In the 21st century we are faced with the potential use of natural or recombinant VARV and MPXV as biological weapons, and the emergence of human MPXV. Such an occurrences would require therapeutic and prophylactic intervention with antivirals. Cidofovir, an antiviral approved for the treatment of c...
Autores principales: | Parker, Scott, Touchette, Erin, Oberle, Christina, Almond, Merrick, Robertson, Alice, Trost, Lawrence C., Lampert, Bernhard, Painter, George, Buller, R. Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628989/ https://www.ncbi.nlm.nih.gov/pubmed/17904231 http://dx.doi.org/10.1016/j.antiviral.2007.08.003 |
Ejemplares similares
-
Development of CMX001 for the Treatment of Poxvirus Infections
por: Lanier, Randall, et al.
Publicado: (2010) -
Mousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies
por: Parker, Scott, et al.
Publicado: (2009) -
Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus
por: Parker, Scott, et al.
Publicado: (2014) -
Efficacy of CMX001 as a Prophylactic and Presymptomatic Antiviral Agent in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans
por: Rice, Amanda D., et al.
Publicado: (2011) -
Efficacy of CMX001 as a Post Exposure Antiviral in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans
por: Rice, Amanda D., et al.
Publicado: (2011)